Live from the NIH registry
Studies recruiting near Greenville right now
Top 25 of 372 recruiting studies, sorted by proximity — each links to its official registry page
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Carolina Nephrology PA — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Amgen
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Single Versus Dual Implant Fixation of Distal Femur Fractures
Articular Fractures
N/A
Interventional 144 participants sought
Prisma Health- Upstate — Greenville, South Carolina (2.0 mi)
· Sponsor: Wake Forest University Health Sciences
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Greenville, South Carolina (2.0 mi)
· Sponsor: AstraZeneca
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Greenville, South Carolina (2.0 mi)
· Sponsor: Dren Bio
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Prisma Health Cancer Institute - Butternut — Greenville, South Carolina (2.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Prisma Health Greenville Memorial Hospital — Greenville, South Carolina (2.0 mi)
· Sponsor: Penumbra Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
AnMed Health Medical Center — Anderson, South Carolina (28.1 mi)
· Sponsor: Duke University
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Phase 3
Interventional 6,000 participants sought
Tribe Clinical Research at Parkside Pediatrics Five Forks — Simpsonville, South Carolina (9.2 mi)
· Sponsor: Pfizer
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
Rhinovirus Infection
Phase 2
Interventional 180 participants sought
Velocity Clinical Research - Spartanburg — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Altesa Biosciences, Inc.
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
BI-LO Charities Children's Cancer Center — Greenville, South Carolina (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Carolina Ottobock.care — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
Prisma Health - Upstate — Greenville, South Carolina (2.0 mi)
· Sponsor: Pfizer
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Tobacco Use, Substance Use Disorders
N/A
Interventional 240 participants sought
Phoenix Center — Greenville, South Carolina (2.0 mi)
· Sponsor: Medical University of South Carolina
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Medtronic
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Saint Francis Health System ( Site 0089) — Greenville, South Carolina (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
Saint Francis Hospital — Greenville, South Carolina (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 798 participants sought
Prisma Health-Upstate Cancer Institute — Greenville, South Carolina (2.0 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Anderson — Anderson, South Carolina (28.1 mi)
· Sponsor: Sparrow Pharmaceuticals
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Supratentorial Hemorrhage
N/A
Observational 500 participants sought
Prisma Health - Upstate — Greenville, South Carolina (2.0 mi)
· Sponsor: Integra LifeSciences Corporation
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Carolina Nephrology, PA — Spartanburg, South Carolina (25.8 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Multiple Myeloma
Phase 3
Interventional 1,594 participants sought
Gibbs Cancer Center — Spartanburg, South Carolina (25.8 mi)
· Sponsor: European Myeloma Network B.V.